Connor, Clark & Lunn Investment Management Ltd.
Position in ORMP — Oramed Pharmaceuticals Inc.
CIK 1596800
VANCOUVER, A1
Position in ORMP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$121,245
-$49,458 QoQ
Shares Held
25,207
-49.8% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 84 holders
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. ORMP ranks #99 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in ORMP
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,245 | 25,207 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $170,703 | 50,207 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $124,644 | 43,735 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $74,561 | 28,243 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $136,010 | 60,449 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $186,471 | 87,136 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $259,090 | 107,062 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $272,106 | 111,519 | Shares | Sole | 2024-11-08 | |
| 2021-12-31 | $725,224 | 50,786 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $568,270 | 25,854 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||